Merck & Co recalls

Merck & Co has 5 recalls on record with the FDA and USDA, the earliest in 2014 and the latest reported on 20 Aug 2025. 1 is still ongoing. The most frequent reason is packaging defects.

Total recalls5since 2014

Last 12 months0reported

Class I00% of total

Ongoing1latest 20 Aug 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 1 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 20%Class III 4 80%

Why merck & co is recalled

Product types

Cholesterol Medication480%

By year

2025120%
2014480%

Ongoing merck & co recalls

1 active

Reported	Class	Recall	Company	Reason	Where
20 Aug 2025Drug	CLASS II	Belsomra (suvorexant) tablets, 10mg in 3 Blister Cards recalledBelsomra	Merck & Co	Potency & Assay	Nationwide

All merck & co recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
20 Aug 2025Drug	CLASS II	Belsomra (suvorexant) tablets, 10mg in 3 Blister Cards recalledBelsomra	Merck & Co	Potency & Assay	Nationwide
14 May 2014Drug	CLASS III	Liptruzet (ezetimibe and atorvastin) tablets,10 mg/80 mg recalled	Merck & Co	Other	Nationwide
14 May 2014Drug	CLASS III	Liptruzet (ezetimibe and atorvastin) tablets,10 mg/10 mg recalled	Merck & Co	Packaging Defects	Nationwide
14 May 2014Drug	CLASS III	Liptruzet (ezetimibe and atorvastin) tablets,10 mg/20 mg recalled	Merck & Co	Packaging Defects	Nationwide
14 May 2014Drug	CLASS III	Liptruzet (ezetimibe and atorvastin) tablets,10 mg/40 mg recalled	Merck & Co	Packaging Defects	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.